High-grade B-cell lymphoma (HGBL)
Clinical trials for High-grade B-cell lymphoma (HGBL) explained in plain language.
Never miss a new study
Get alerted when new High-grade B-cell lymphoma (HGBL) trials appear
Sign up with your email to follow new studies for High-grade B-cell lymphoma (HGBL), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug combo aims to tackle tough lymphoma cases
Disease control Recruiting nowThis study tests whether combining two drugs, loncastuximab tesirine and epcoritamab, can safely and effectively treat people with aggressive B-cell lymphoma that has come back or not responded to prior therapy. The trial will include 120 adults who have either not had CAR-T cell…
Matched conditions: HIGH-GRADE B-CELL LYMPHOMA (HGBL)
Phase 2 • Sponsor: Universität Münster • Aim: Disease control
Last updated Aug 01, 2026 00:00 UTC
-
Engineered immune cells take on tough lymphoma
Disease control Recruiting nowThis study tests a new treatment called TC011, which uses a patient's own immune cells engineered to find and attack lymphoma cells. It is for adults with large B-cell lymphoma that has come back or not responded to at least two prior treatments. The trial will check safety and h…
Matched conditions: HIGH-GRADE B-CELL LYMPHOMA (HGBL)
Phase 1/2 • Sponsor: TICAROS Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC